Dabigatran vs Durvalumab

## Dabigatran vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Durvalumab**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Durvalumab — N/A.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Durvalumab — N/A.

**Type**: Dabigatran — Small molecule; Durvalumab — Antibody.